By eCliniqua Staff

April 23, 2013 | In a survey conducted by CenterWatch, clinical trial investigator sites and study sponsors reported that most accessed many clinical portals, and an integrated solution would be welcome.

The 2013 Intralinks Web Portal Survey, sponsored by Intralinks, looked at how clinical investigator sites currently perceive clinical web portals. The survey tallied responses from 551 clinical professionals and patients. Seventy six percent of respondents were based in North America, 17% in Europe, 5% in Asia Pacific and 2% in other areas.

A vast majority—88%—regularly access three or more clinical portals; 53% access six or more. Multiple portals makes it challenging for managers to prioritize tasks across trials.
 
“The current complexity in how investigator sites communicate with study sponsors and CROs make it difficult for all parties to track information and make timely decisions,” said Kevin McNulty, director of product marketing for life sciences at Intralinks in a statement. “Deploying a single web-based clinical trial portal would enable sponsors and clinical research organizations (CROs) to work faster, cut down on inefficiencies and help speed time to market.”

Survey responses suggest that investigator sites and study sponsors need a single portal on a multi-tenant cloud architecture with integration to multiple clinical applications, including electronic data capture, clinical trial management systems, safety systems, interactive voice response systems and learning management systems with an easy-to-use user-interface and single-sign-on.

Respondents included a wish list for such an integrated system. They want something that will include study and regulatory documents; study announcements and changes; training documents; query status; study timeline; and patient recruitment information.

Intralinks is a leading global technology provider of content management and collaboration solutions that expedites the product lifecycle by facilitating communication throughout the process from clinical site scouting to regulatory reporting.